Abstract

Abundant heterogeneous immune cells infiltrate lesions in chronic inflammatory diseases and characterization of these cells is needed to distinguish disease-promoting from bystander immune cells. Here, we investigate the landscape of non-communicable inflammatory skin diseases (ncISD) by spatial transcriptomics resulting in a large repository of 62,000 spatially defined human cutaneous transcriptomes from 31 patients. Despite the expected immune cell infiltration, we observe rather low numbers of pathogenic disease promoting cytokine transcripts (IFNG, IL13 and IL17A), i.e. >125 times less compared to the mean expression of all other genes over lesional skin sections. Nevertheless, cytokine expression is limited to lesional skin and presented in a disease-specific pattern. Leveraging a density-based spatial clustering method, we identify specific responder gene signatures in direct proximity of cytokines, and confirm that detected cytokine transcripts initiate amplification cascades of up to thousands of specific responder transcripts forming localized epidermal clusters. Thus, within the abundant and heterogeneous infiltrates of ncISD, only a low number of cytokine transcripts and their translated proteins promote disease by initiating an inflammatory amplification cascade in their local microenvironment.

Inflammatory skin diseases involve various different immune cells in a localised area. Here the authors use spatial transcriptomics to show that disease relevant cytokine transcripts are sparsely expressed in lesional skin, yet are associated with local amplification cascades that promote skin inflammation.

Details

Title
Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases
Author
Schäbitz, A. 1   VIAFID ORCID Logo  ; Hillig, C. 2 ; Mubarak, M. 3 ; Jargosch, M. 4 ; Farnoud, A. 2 ; Scala, E. 5 ; Kurzen, N. 3   VIAFID ORCID Logo  ; Pilz, A. C. 6 ; Bhalla, N. 7   VIAFID ORCID Logo  ; Thomas, J. 3 ; Stahle, M. 1 ; Biedermann, T. 8   VIAFID ORCID Logo  ; Schmidt-Weber, C. B. 3   VIAFID ORCID Logo  ; Theis, F. 2   VIAFID ORCID Logo  ; Garzorz-Stark, N. 9 ; Eyerich, K. 10 ; Menden, M. P. 11   VIAFID ORCID Logo  ; Eyerich, S. 3   VIAFID ORCID Logo 

 Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 Institute of Computational Biology, Helmholtz Zentrum München—German Research Centre for Environmental Health, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 Technical University and Helmholtz Center Munich, Center for Allergy and Environment (ZAUM), Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966) 
 Technical University and Helmholtz Center Munich, Center for Allergy and Environment (ZAUM), Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966); Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966) 
 Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Dermatology and Venerology, Freiburg, Germany (GRID:grid.5963.9) 
 Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966); Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Dermatology and Venerology, Freiburg, Germany (GRID:grid.5963.9) 
 Biotechnology and Health, KTH Royal Institute of Technology, Department of Gene Technology, School of Engineering Sciences in Chemistry, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746) 
 Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966) 
 Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966) 
10  Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Dermatology and Venerology, Freiburg, Germany (GRID:grid.5963.9); Unit of Dermatology, Karolinska University Hospital, Department of Dermatology and Venereology, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705) 
11  Institute of Computational Biology, Helmholtz Zentrum München—German Research Centre for Environmental Health, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Ludwig-Maximilians University, Department of Biology, Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany (GRID:grid.452622.5) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2753902755
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.